PCMA: CREATES Act to Increase Access to Generic Drugs

Tuesday, June 21, 2016 Drug News J E 4
Competition is the Key to Reducing Drug Costs

WASHINGTON, June 21, 2016 /PRNewswire-USNewswire/ -- Today's Senate Judiciary Subcommittee hearing on S. 3056, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, is an important step toward promoting competition and affordability in the prescription drug marketplace, the Pharmaceutical Care Management Association (PCMA) said.

The bipartisan legislation, introduced by Senators Charles Grassley (R-IA), Patrick Leahy (D-VT), Amy Klobuchar (D-MN), and Mike Lee (R-UT), will encourage more development of generic and biosimilar drugs and reduce overall drug costs by preventing brand drug manufacturer abuses of risk evaluation and mitigation strategies (REMS) that block generic competition.

The CREATES Act addresses this problem in a number of ways, including by allowing parties to bring actions in federal court to obtain drug samples necessary to develop generic versions of brand drugs. It also would authorize judges to award damages to prevent future similar abuses.

"This legislation will help bring generics to market faster, which is key to reducing drug costs," said PCMA President and CEO Mark Merritt.

The legislation is supported by a broad group of stakeholders, including the Generic Pharmaceutical Association, the Academy of Managed Care Pharmacy, Public Citizen, Consumers Union, and the Blue Cross Blue Shield Association. 

Other potential solutions for high drug prices that the Food and Drug Administration and Congress could consider include:

  • Accelerating FDA approvals of drugs that face little or no competition;
  • Making copay coupons an illegal kickback for all insurance that receives any federal subsidy;
  • Modernizing Medicaid pharmacy to make it more like the commercial market and Medicare Part D; and
  • Creating new incentives for physicians to prescribe biosimilars.

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.


To view the original version on PR Newswire, visit:

SOURCE Pharmaceutical Care Management Association



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
"Miracle Man" Novel Exposes Big Pharma Greed Befor...
Phoenix Children's Hospital Now Ranked in All 10 S...